The article examines conspiracy theories that Morgan Stanley and MSCI orchestrated Bitcoin's Q4 2025 crash to accumulate coins cheaply before launching ETFs. It debunks four main myths by analyzing market mechanics, leverage, macroeconomic factors, and regulatory developments, concluding that while TradFi's crypto embrace creates imbalances favoring institutions, it's not evidence of coordinated manipulation but rather normal market opportunism amid the merger of traditional finance and crypto.

MSCI reported Q2 2025 financial results with revenue of $772.7 million, exceeding expectations. While core segments showed stable growth, the company experienced slower new business, particularly in sustainability and climate products.

Resmed, a global leader in health technology, has appointed Salli Schwartz as its new Chief Investor Relations Officer. Schwartz brings extensive experience from her previous roles at Illumina, MSCI, and Moody's, and will lead Resmed's global investor relations function.

BofA analysts expect mostly in-line or better Q1 earnings for industrial companies, with Q3 flagged as a potential earnings trough. They highlight 3M, Johnson Controls, and GE Vernova as top picks, despite lowering EPS estimates due to tariff uncertainty.

MSCI, a leader in investment decision support tools, reported mixed Q4 earnings. While adjusted EPS beat expectations, revenue fell slightly short. The company saw solid earnings amidst lower net income, driven by the absence of previous period gains. MSCI remains focused on expanding its Index and ESG offerings, though it faces some operational headwinds.

The article discusses the potential for US stocks to continue outperforming in 2025, with the S&P 500 expected to rise 19.0% to 7000. However, the author expects a bumpier ascent, with the Federal Reserve likely to be less dovish and uncertainty around fiscal, trade, and immigration policies potentially putting upward pressure on bond yields.

Goldman Sachs maintained a neutral stance on MSCI Inc. shares, citing the company's strong Q2 earnings that surpassed consensus expectations in revenue, EBITDA margins, and EPS. However, the firm noted a relatively modest year-over-year increase in index recurring subscription organic revenue.

MSCI reported a second-quarter adjusted profit that rose nearly 12% as improved spending by clients drove up demand for the company's index products and analytics services.

Moody's (MCO) enters into a strategic partnership with MSCI to augment its ESG solutions. The financial terms of the deal remain undisclosed. This move aligns with the company's organic growth strategy.

MSCI (MSCI) and Moody's join forces to enhance ESG transparency for markets worldwide by integrating MSCI's robust data with Moody's expertise.

MSCI is a strong GARP investment opportunity with consistent growth and attractive valuation. See why we believe MSCI stock is buy rated.

ECB President Christine Lagarde said underlying pressure in the European economy has eased.